Cardiovascular involvement in metabolic diseases.

Area of Science:

• Cardiology
• Internal Medicine
• Genetics

Background:

• Cardiomyopathies encompass myocardial contractility dysfunction, leading to reduced cardiac function.
• These disorders can be primary/idiopathic or secondary to systemic conditions.
• The World Health Organization classifies cardiomyopathies into dilated, obstructive (hypertrophic), and restrictive types, with additional categories for arrhythmogenic right ventricular and unclassified cardiomyopathies.

Purpose of the Study:

• To provide a comprehensive overview of cardiomyopathy classifications and their underlying causes.
• To highlight the significance of metabolic disorders as a cause of cardiomyopathy.
• To emphasize the critical link between cardiomyopathies and mortality rates.

Main Methods:

• Literature review of existing classifications and etiological factors of cardiomyopathies.
• Analysis of World Health Organization (WHO) categorization of cardiomyopathies.
• Examination of the role of metabolic disorders in the pathogenesis of cardiomyopathy.

Main Results:

• Cardiomyopathies are categorized into several distinct types based on structural and functional characteristics.
• Secondary cardiomyopathies can arise from a wide range of systemic and metabolic disorders.
• Metabolic disorders represent a significant cause of cardiomyopathy and are frequently associated with mortality.

Conclusions:

• Understanding the diverse etiologies and classifications of cardiomyopathies is crucial for diagnosis and management.
• Metabolic disorders are an important, often fatal, cause of cardiomyopathy that requires specific attention.
• Further research into the mechanisms of metabolic cardiomyopathies may improve patient outcomes.